Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Embecta Corp., 3 years.
Embecta Corp.
Director
BioMarin Pharmaceutical Inc.
Director
Henry Schein Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +4,720 | — | — |
| Feb 7, 2024 | Embecta Corp. | Grant or award | +11,455 | — | — |
| May 23, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +4,190 | — | — |
| Feb 9, 2023 | Embecta Corp. | Grant or award | +6,979 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.